Herbalife(HLF)

Search documents
Herbalife(HLF) - 2024 Q4 - Earnings Call Presentation
2025-02-20 02:38
Q4 2024 Earnings Presentation February 19, 2025 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the p ...
Herbalife(HLF) - 2024 Q4 - Earnings Call Transcript
2025-02-20 02:38
Financial Data and Key Metrics Changes - For Q4 2024, reported net sales were $1.2 billion, down 0.6% year-over-year, but up 2.7% on a constant currency basis [39][40] - Full year 2024 net sales were $5 billion, down 1.4% year-over-year, but up 1.2% on a constant currency basis [41][42] - Adjusted EBITDA for Q4 was $150 million, exceeding guidance, with a margin of 12.4%, up 340 basis points year-over-year [43][58] - Full year adjusted EBITDA was $635 million, significantly up from $571 million in 2023, with a margin of 12.7%, up 140 basis points [44][70] Business Line Data and Key Metrics Changes - New distributor growth was up 22% year-over-year in Q4, marking the third consecutive quarter of growth, and up 11% for the full year compared to 2023 [26][29] - Active non-sales leaders showed year-over-year growth for the third consecutive quarter, indicating a positive trend in distributor engagement [28][31] - Sales leader retention rate improved from 68.3% to 70.3% year-over-year, reflecting better distributor support and training initiatives [31][70] Market Data and Key Metrics Changes - Latin America reported net sales growth of 2% on a reported basis and 15% on a local currency basis [51] - EMEA net sales were up 3% year-over-year on a reported basis and 6% on a local currency basis [53] - Asia-Pacific net sales increased by 1% on a reported basis and 3% on a local currency basis [54] - North America saw a decline of 3% year-over-year in net sales, but trends showed improvement over the last three quarters [55][81] - China experienced a significant decline of 20% year-over-year in net sales, attributed to volume declines and strategic shifts [57][99] Company Strategy and Development Direction - The company aims to become one of the world's most important health and wellness platforms, focusing on digital transformation and distributor engagement [24][34] - Initiatives launched in 2024 to rebuild the distributor base and improve activity levels are yielding positive results [25][31] - The company is addressing market-specific challenges with optimization strategies, particularly in Latin America [30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the improving distributor metrics and the potential for growth in 2025, despite currency headwinds [70][72] - The company is focused on leveraging industry disruptors and adapting to changing consumer trends [33][72] - Management acknowledged the challenges in the North American market but indicated that improvements are on track [80][82] Other Important Information - The company reduced its total leverage ratio to 3.2 times as of December 31, down from 3.9 times at the end of 2023 [48][61] - The company plans to pay down $1 billion of debt by the end of 2028, with a target to reduce debt to $1.4 billion [61][62] - The company is experiencing a significant currency headwind, projected to impact 2025 net sales and adjusted EBITDA [63][66] Q&A Session Summary Question: What needs to happen to turn around North American volume trends? - Management indicated the need to rebuild the distributor and supervisor base, with positive signs of improvement after 14 quarters of decline [78][80] Question: Is the plan to repay the 2025 maturity just once it comes due in September? - Management confirmed the plan to repay the 2025 notes in September, with some revolver drawn to assist in the repayment [83][84] Question: Can you discuss the constant currency sales guidance range for 2025? - Management explained that the wide range reflects potential opportunities in China and the US, with more upside than downside risks [89][90] Question: What is the situation in China regarding revenue decline? - Management noted a strategic shift towards a customer-focused approach, which has yielded some positive results but is still in transition [98][100] Question: How do you view the preferred customer declines in North America? - Management acknowledged the need to balance transactional and transformational aspects of the business to improve preferred customer metrics [103][106]
Herbalife(HLF) - 2024 Q4 - Annual Results
2025-02-19 21:30
Financial Performance - Q4 2024 net sales were $1.2 billion, down 0.6% year-over-year, but up 2.7% on a constant currency basis[5]. - Full-year 2024 net sales totaled $5.0 billion, a decrease of 1.4% year-over-year, with a 1.2% increase on a constant currency basis[10]. - Adjusted EBITDA for Q4 2024 was $150.0 million, exceeding guidance, with an adjusted EBITDA margin of 12.4%, up 340 basis points from Q4 2023[8]. - Full-year 2024 adjusted EBITDA reached $634.8 million, with an adjusted EBITDA margin of 12.7%, up 140 basis points compared to 2023[10]. - Net income for Q4 2024 was $177.9 million, significantly up from $10.2 million in Q4 2023, representing a year-over-year increase of 1,642.2%[39]. - Net income for the year ended December 31, 2024, increased to $254.3 million, up from $142.2 million in 2023, representing a growth of 78.9%[44]. - Adjusted net income for Q4 2024 was $36.8 million, compared to $28.6 million in Q4 2023, with full-year adjusted net income at $198.9 million, down from $221.8 million[51]. - EBITDA for the year ended December 31, 2024, was $496.8 million, compared to $470.7 million in 2023, indicating a year-over-year growth[51]. - Adjusted EBITDA for the year was $634.8 million, up from $570.6 million in 2023, reflecting a strong operational performance[52]. - The adjusted EBITDA margin for 2024 was 12.7%, compared to 11.3% in 2023, showcasing improved profitability[52]. Sales and Guidance - First quarter 2025 net sales guidance is projected to decline between 5.5% to 1.5% year-over-year[24]. - Full-year 2025 net sales guidance is expected to range from a decline of 3% to an increase of 3% year-over-year[25]. - The company reported a net sales figure of $4,993.1 million for 2024, a decrease from $5,062.4 million in 2023[51]. Cost Management and Restructuring - The company expects annual savings of at least $80 million from its Restructuring Program starting in 2025[12]. - The company incurred $69.1 million in restructuring program expenses for the year, compared to none in the previous year, indicating ongoing transformation efforts[51]. - Capital expenditures for full-year 2024 were $122.0 million, with guidance for 2025 set between $100 million and $130 million[11][25]. Debt and Financial Position - The company redeemed $65.0 million of its 7.875% Senior Notes due 2025, reducing the outstanding principal balance to $197.3 million[13]. - Total debt as of the end of 2024 was $2,332.7 million, down from $2,581.1 million in 2023, reflecting effective debt management[52]. - Principal payments on debt rose to $1,937.0 million in 2024 from $289.6 million in 2023, indicating a substantial increase in debt repayment activity[44]. - The leverage ratio under the Credit Agreement improved to 3.2x in 2024 from 3.9x in 2023, indicating a stronger balance sheet[52]. Assets and Liabilities - Total assets decreased to $2,728.1 million in 2024 from $2,809.4 million in 2023, a decline of 2.9%[42]. - Total liabilities decreased to $3,529.2 million in 2024 from $3,869.7 million in 2023, a reduction of 8.8%[42]. - The company reported a decrease in cash and cash equivalents to $415.3 million in 2024 from $575.2 million in 2023, a decline of 27.8%[42]. - Cash, cash equivalents, and restricted cash at the end of the period was $438.1 million, down from $595.5 million at the end of 2023, a decrease of 26.5%[44]. Market Strategy and Outlook - The company plans to continue focusing on expanding its market presence and enhancing its product offerings in 2025[33]. - The outlook for 2025 does not account for potential impacts from incremental tariffs, indicating a cautious approach to future projections[29]. - The company aims to improve its operational efficiency and strengthen its supply chain management to mitigate risks associated with global economic conditions[35]. - The company plans to continue focusing on international operations, which are expected to contribute significantly to total net sales[49]. Currency Impact - The company emphasized the impact of currency fluctuations on total net sales, which are significantly affected by the U.S. dollar against foreign currencies[49]. - The company experienced a foreign exchange transaction loss of $7.6 million in 2024, compared to a loss of $6.0 million in 2023[44].
Herbalife(HLF) - 2024 Q4 - Annual Report
2025-02-19 21:22
Financial Performance - Net sales for the year ended December 31, 2024, were $4,993.1 million, a decrease of $69.3 million, or 1.4%, compared to 2023[287] - Net income for the year ended December 31, 2024, was $254.3 million, or $2.50 per diluted share, an increase of $112.1 million, or 78.8%, compared to 2023[288] - The Primary Reporting Segment reported net sales of $4,695.5 million for the year ended December 31, 2024, a decrease of $39.5 million, or 0.8%, compared to 2023[292] - Contribution margin for the Primary Reporting Segment was $2,004.3 million, or 42.7% of net sales, for the year ended December 31, 2024, an increase of $66.5 million, or 3.4%, compared to 2023[295] - The decrease in net sales for 2024 was primarily driven by a 4.0% decrease in Volume Points and a 2.6% unfavorable impact from foreign currency exchange rates[287] - In local currency, net sales increased by 1.2% for the year ended December 31, 2024, compared to the same period in 2023[287] - The company experienced a 5.3% favorable impact from price increases, partially offsetting the decrease in sales volume[287] Regional Performance - Net sales in North America were $1,054.4 million for the year ended December 31, 2024, a decrease of $77.0 million, or 6.8%, compared to the same period in 2023[298] - Latin America reported net sales of $832.5 million for the year ended December 31, 2024, an increase of $11.6 million, or 1.4%, compared to 2023[301] - EMEA region net sales were $1,084.8 million for the year ended December 31, 2024, an increase of $16.0 million, or 1.5%, compared to 2023[306] - Asia Pacific region, excluding China, reported net sales of $1,723.8 million for the year ended December 31, 2024, an increase of $9.9 million, or 0.6%, compared to 2023[309] - The China region reported net sales of $297.6 million for the year ended December 31, 2024, a decrease of $29.8 million, or 9.1%, compared to 2023[313] Cost and Expense Management - The company continues to assess its cost structure and potential pricing actions in response to ongoing inflationary pressures[286] - Selling, general, and administrative expenses rose to $1,875.4 million in 2024, representing 37.6% of net sales, compared to 36.9% in 2023[321] - The Transformation Program is expected to deliver annual savings of approximately $110 million, with $110 million realized in 2024[334] - The Restructuring Program is projected to yield annual savings of at least $80 million starting in 2025, with $50 million already realized in 2024[335] Cash Flow and Capital Expenditures - Operating cash flow for 2024 was $285.4 million, down from $357.5 million in 2023, primarily due to lower net income and unfavorable changes in operating assets and liabilities[331] - Capital expenditures for 2024 were $112.2 million, down from $140.1 million in 2023, with a focus on management information systems and the $400 million Digital Technology Program[332] - As of December 31, 2024, the company had $415.3 million in cash and cash equivalents, supporting general corporate purposes and potential strategic investments[330] Debt and Financing - The company entered into the 2024 Credit Facility, which includes a $400.0 million Term Loan B Facility and a $400.0 million revolving credit facility[339] - The company repaid $1,917.9 million in total debt during the year ended December 31, 2024, including $831.2 million under the 2024 Credit Facility[346] - As of December 31, 2024, the outstanding principal on the 2029 Secured Notes was $800.0 million, with an interest rate of 12.250% per annum[348] - The company recognized a loss on extinguishment of approximately $2.5 million related to the repayment of the 2018 Credit Facility[341] - The 2024 Revolving Credit Facility requires a maximum total leverage ratio of 4.50:1.00 through December 31, 2024, stepping down to 4.00:1.00 by September 30, 2025[344] Tax and Accounting - The effective income tax rate for 2024 was (50.1)%, influenced by corporate entity structure changes and a deferred income tax asset of $177.6 million recognized during the year[328] - The company is required to estimate income taxes in each jurisdiction prior to filing tax returns, which involves complex judgments and may take extended periods for resolution[379] - The realizability of deferred income tax assets is assessed by adjusting the valuation allowance, which could materially impact consolidated financial statements[380] - Tax benefits from uncertain tax positions are recognized only if it is more likely than not that the position will be sustained upon examination by taxing authorities[381] Shareholder Returns and Dividends - The company has not declared or paid cash dividends since 2014, with future declarations subject to board discretion and various factors[361] - The share repurchase program authorized in February 2021 had approximately $985.5 million of remaining capacity prior to expiration on February 9, 2024[362] Miscellaneous - Product returns and buybacks were approximately 0.1% of net sales for both years ended December 31, 2024 and 2023[372] - Goodwill decreased from approximately $95.4 million in 2023 to $87.7 million in 2024 due to foreign currency translation adjustments[377] - The company expects sufficient working capital from operations and available borrowings to meet liquidity requirements for the next twelve months[365] - Foreign subsidiaries' asset and liability accounts are translated into U.S. dollars at period-end exchange rates for consolidated financial reporting[383]
Herbalife: A Top Short Squeeze Idea, Turning Higher In Price
Seeking Alpha· 2024-11-05 00:59
Core Insights - The article highlights the investment strategies and achievements of Paul Franke, a seasoned investor with 38 years of trading experience, emphasizing his contrarian stock selection style and algorithmic analysis of market data [1] Group 1: Investment Strategies - Paul Franke developed a system called "Victory Formation," which focuses on identifying supply/demand imbalances through specific stock price and volume movements [1] - The "Bottom Fishing Club" articles target deep-value stocks or those showing significant upward technical momentum reversals [1] - The "Volume Breakout Report" articles analyze positive trend changes supported by strong price and volume trading activity [1] Group 2: Performance and Recognition - Franke was consistently ranked among the top investment advisors nationally during the 1990s and achieved the 1 position in the Motley Fool® CAPS stock picking contest in 2008 and 2009, out of over 60,000 portfolios [1] - As of September 2024, he is ranked in the Top 3% of bloggers by TipRanks® for 12-month stock picking performance over the last decade [1] Group 3: Risk Management - Franke advises investors to implement stop-loss levels of 10% or 20% on individual stock choices and to maintain a diversified portfolio of at least 50 well-positioned stocks to enhance regular stock market outperformance [1]
Why Herbalife Stock Crushed the Market Today
The Motley Fool· 2024-10-31 21:37
The market was impressed with the company's third-quarter earnings.Investors liked the news they heard about multilevel nutrition-supplement company Herbalife (HLF 10.87%) on Thursday. The company released rather pleasing quarterly results and was rewarded with a nearly 11% boost in its share price. This occurred on a day when the bellwether S&P 500 index was notably in negative territory, closing 1.9% lower.A pair of declinesHerbalife's third-quarter earnings, published just after market hours on Wednesday ...
Herbalife(HLF) - 2024 Q3 - Earnings Call Presentation
2024-10-31 02:35
WORLDWIDE WORKOUT2024 ONE DAY ONE GOAL ONE GLOBAL EVENT Largest High-Intensity Interval Training Class September 21, 2024 Herbalife Q3 2024 Earnings Presentation October 30, 2024 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are "forward-looking statements" for purposes of ...
Herbalife(HLF) - 2024 Q3 - Earnings Call Transcript
2024-10-31 02:31
Herbalife Ltd. (NYSE:HLF) Q3 2024 Earnings Conference Call October 30, 2024 5:30 PM ET Company Participants Erin Banyas - VP & Head, IR Michael Johnson - Chairman & CEO Stephan Gratziani - President John DeSimone - CFO Conference Call Participants Jeff Van Sinderen - B. Riley Securities Chasen Bender - Citi Hale Holden - Barclays John Baumgartner - Mizuho Securities Linda Bolton-Weiser - D.A. Davidson Karru Martinson - Jefferies Operator Good afternoon and thank you for joining the Third Quarter 2024 Earnin ...
Herbalife Ltd (HLF) Q3 Earnings and Revenues Surpass Estimates
ZACKS· 2024-10-30 23:50
Financial Performance - Herbalife Ltd reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, but down from $0.65 per share a year ago, representing an earnings surprise of 200% [1] - The company posted revenues of $1.24 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.67%, compared to year-ago revenues of $1.28 billion [2] - Over the last four quarters, Herbalife has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Herbalife shares have declined approximately 54.4% since the beginning of the year, contrasting with the S&P 500's gain of 22.3% [3] - The current Zacks Rank for Herbalife is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.11 on revenues of $1.19 billion, and for the current fiscal year, it is $1.34 on revenues of $4.97 billion [7] - The estimate revisions trend for Herbalife is mixed, and changes in these estimates may occur following the recent earnings report [6] Industry Context - The Retail - Pharmacies and Drug Stores industry, to which Herbalife belongs, is currently ranked in the bottom 6% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The performance of Herbalife's stock may be influenced by the overall outlook for the industry [8]
Herbalife(HLF) - 2024 Q3 - Quarterly Results
2024-10-30 20:18
Exhibit 99.1 Herbalife Reports Third Quarter 2024 Results Net Sales In Line with Expectations, Adjusted EBITDAExceeds Guidance; Raised Full-Year Adjusted EBITDA Guidance LOS ANGELES, October 30, 2024 – Herbalife Ltd. (NYSE: HLF) today reported financial results for the third quarter ended September 30, 2024: Highlights Third Quarter 2024 ● Net sales of $1.2 billion, down 3.2% vs. Q3 '23 including 290 basis points of FX headwinds ● Credit Agreement EBITDA $197.2 million; total leverage ratio reduced to 3.3x ...